BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

575 hedge funds and large institutions have $18.9B invested in BioMarin Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 87 funds opening new positions, 198 increasing their positions, 202 reducing their positions, and 48 closing their positions.

Holders
575
Holders Change
+28
Holders Change %
+5.12%
% of All Funds
9.28%
Holding in Top 10
15
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+15.38%
% of All Funds
0.24%
New
87
Increased
198
Reduced
202
Closed
48
Calls
$185M
Puts
$117M
Net Calls
+$68.2M
Net Calls Change
+$35.2M

Top Buyers

1
Invesco
1
Invesco
Georgia
$190M
2
CG
2
Carmignac Gestion
France
$89.9M
3
Capital Research Global Investors
3
Capital Research Global Investors
California
$585M
4
PAMS
4
Pictet Asset Management (Switzerland)
Switzerland
$153M
5
Bank of New York Mellon
5
Bank of New York Mellon
New York
$176M

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$402M
2
Millennium Management
2
Millennium Management
New York
$81.3M
3
Ameriprise
3
Ameriprise
Minnesota
$481M
4
Citadel Advisors
4
Citadel Advisors
Florida
$13.5M
5
PHS
5
PFM Health Sciences
California
$32.1M
Name Market Value Shares Shares
Change 		Shares
Change %
Charles Schwab
26
Charles Schwab
California
$129M 1,241,980 +26,963 +2%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$128M 1,233,289 -91,719 -7%
Goldman Sachs
28
Goldman Sachs
New York
$121M 1,171,051 +388,026 +50%
Legal & General Group
29
Legal & General Group
United Kingdom
$121M 1,168,215 -63,752 -5%
FWIA
30
Fort Washington Investment Advisors
Ohio
$119M 1,146,055 +459 +0%
Bank of America
31
Bank of America
North Carolina
$119M 1,145,414 -78,091 -6%
1832 Asset Management
32
1832 Asset Management
Ontario, Canada
$117M 1,125,806 -276,246 -20%
ClearBridge Investments
33
ClearBridge Investments
New York
$114M 1,102,289 -71,414 -6%
Morgan Stanley
34
Morgan Stanley
New York
$113M 1,095,356 +276,841 +34%
UBS AM
35
UBS AM
Illinois
$105M 1,013,561 -260,605 -20%
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$96M 927,836 +316,129 +52%
Adage Capital Partners
37
Adage Capital Partners
Massachusetts
$95.2M 920,000 +70,000 +8%
MNG
38
Manning & Napier Group
New York
$90.5M 874,566 -57,225 -6%
CG
39
Carmignac Gestion
France
$89.9M 868,612 +868,612 New
Millennium Management
40
Millennium Management
New York
$81.3M 785,450 -1,088,822 -58%
Two Sigma Investments
41
Two Sigma Investments
New York
$79.3M 766,372 +336,437 +78%
Swiss National Bank
42
Swiss National Bank
Switzerland
$78M 753,800 -47,998 -6%
Two Sigma Advisers
43
Two Sigma Advisers
New York
$76.3M 736,914 +340,800 +86%
Point72 Asset Management
44
Point72 Asset Management
Connecticut
$74.2M 716,700 +121,300 +20%
Assenagon Asset Management
45
Assenagon Asset Management
Luxembourg
$72.9M 704,748 +313,566 +80%
UBS Group
46
UBS Group
Switzerland
$69.1M 667,284 -437,947 -40%
Man Group
47
Man Group
United Kingdom
$68.7M 663,969 +115,421 +21%
Renaissance Technologies
48
Renaissance Technologies
New York
$65.2M 630,271 -114,200 -15%
FCM
49
Frontier Capital Management
Massachusetts
$63.4M 612,349 -147,191 -19%
Marshall Wace
50
Marshall Wace
United Kingdom
$62.1M 600,272 +139,313 +30%
1
2
3 4 5